“ received FDA clearance for the new 4 French (4 Fr) 1.25 Solid Diamondback 360® Peripheral Orbital Atherectomy System (OAS) for the treatment of peripheral artery disease (PAD). Specifically, the clearance covers the company’s 145cm long: New 1.25mm Diamondback 360 Solid Crown, 4 Fr sheath com
“ received FDA clearance for the new 4 French (4 Fr) 1.25 Solid Diamondback 360® Peripheral Orbital Atherectomy System (OAS) for the treatment of peripheral artery disease (PAD). Specifically, the clearance covers the company’s 145cm long: New 1.25mm Diamondback 360 Solid Crown, 4 Fr sheath com
このブックマークにはスターがありません。
最初のスターをつけてみよう！
CSI360 | Investor Relations | News Release
1 人がブックマーク・1 件のコメント
＼ コメントが サクサク読める アプリです ／